Practical, sourced food strategies for the gastrointestinal effects most commonly reported on GLP-1 medications — nausea, constipation, reflux and early fullness — plus which Smash Meals options many customers reach for when appetite is low. Nutrition information, not medical advice.
Order Meals — View This Week's Menu
Nausea, vomiting, diarrhea and constipation are the most commonly reported adverse reactions in the FDA prescribing information for semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Most people manage the food side with four adjustments: smaller portions eaten more often, protein first, less fat per meal, and steady fluid and fiber intake. Tolerance varies by person and by dose, and severe or persistent symptoms are a reason to call your prescriber rather than change your diet.
Call your prescriber for severe abdominal pain, persistent vomiting, dehydration, or symptoms suggesting pancreatitis or gallbladder disease. This page is food guidance, not treatment.
SmashMeals cooks in a 100% dedicated gluten-free facility — no wheat, barley or rye enters the building — and every entrée carries posted macros, so a small portion is easy to plan around.
Reviewed August 27, 2026 by the SmashMeals editorial team against current FDA prescribing information and NIH/NIDDK guidance. Nutrition information, not medical advice — meal tolerance and nutrition needs vary, so follow your prescriber's or dietitian's guidance.
SmashMeals is a food company, not a medical provider. Ozempic and Wegovy are registered trademarks of Novo Nordisk; Mounjaro and Zepbound are registered trademarks of Eli Lilly. We are not affiliated with, endorsed by, or sponsored by either manufacturer.
See this week's menu and order — or read how ordering, pickup and shipping work.